Psychotropic Drug Use in a Nursing Home: A 6-Year Retrospective

Journal of Applied Gerontology

Volumn 22, Issue 4, 2003, Pages 474-489

  Taylor, Leslie F ^a   Whittington, Frank ^a   Strasser, Dale C ^b   Miller, Susan W ^c   Hennessy, Catherine Hagan ^d   Archea, Connie ^e  

^a GEORGIA STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

^c MERCER UNIVERSITY   (United States)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Long term care; OBRA; Psychotropic drugs

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

AGED; ARTICLE; CAREGIVER; COGNITIVE DEFECT; DATA ANALYSIS; FEMALE; GERIATRIC CARE; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MIXED DEPRESSION AND DEMENTIA; NURSING HOME; PRESCRIPTION; RETROSPECTIVE STUDY;

EID: 0345448340     PISSN: 07334648     EISSN: None     Source Type: Journal    
DOI: 10.1177/0733464803254337     Document Type: Article

References (14)

1. Avorn, J., & Gurwitz, J. H. (1995). Drug use in the nursing home. Annals of Internal Medicine, 123(3), 195-204.
2. Borson, S., & Doane, K. (1997). The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities. Psychiatric Services, 48, 1289-1296.
3. Castle, N. G. (1999). Changes in resident and facility risk factors for psychotropic drug use in nursing homes since the nursing home reform act. Journal of Applied Gerontology, 18, 77-98.
4. Dodds, S. (1996). Exercising restraint: Autonomy welfare and elderly patients. Journal of Medical Ethics, 22(3), 160-163.
5. Durkheim, E. (1897). Suicide (J. A. Spaulding, Trans.). New York: Free Press.
6. Hennessy, C. H., McNeely, E. A., Whittington, F. J., Strasser, D. C., & Archea, C. A. (1997). Perceptions of physical restraint use and barriers to restraint reduction in a long-term care facility. Journal of Aging Studies, 11, 49-62.
7. Kane, R. L., Williams, C. C., Williams, T. F., & Kane, R. A. (1993). Restraining restraints: Changes in a standard of care. Annual Review of Public Health, 14, 545-584.
8. Llorente, M. D., Olsen, E. J., Leyva, O., Silverman, M. A., Lewis, J. E., & Rivero, J. (1998). Use of AP drugs in nursing homes: Current compliance with OBRA regulations. Journal of the American Geriatrics Society, 46, 198-201.
9. Nelson, J. C. (2001). Diagnosing and treating depression in the elderly. Journal of Clinical Psychiatry, 62(Suppl. 24), 18-22.
10. Ouslander, J. G. (1994). Maximizing the minimum data set. Journal of the American Geriatrics Society, 42, 1212-1213.
11. Phillips, C. D., Spry, K. M., Sloane, P. D., & Hawes C. (2000). Use of physical restraints and psychotropic medications in Alzheimer special care units in nursing homes. American Journal of Public Health, 90, 92-96.
12. Slater, E. J., & Glazer, W. (1995). Use of OBRA-87 guidelines for prescribing neuroleptic in a VA nursing home. Psychiatric Services, 46, 119-121.
13. U.S. Congress. (1987). Omnibus Budget Reconciliation Act of 1987. Washington, DC: 100th Congress, 1st Session, Pub. Law 100-175.
14. Whittington, F. J., Strasser, D. C., Archea, C. S., Hennessy, C. H., Miller, S. W., & McNeely, E. et al. (2002). Changes in restraint use in a nursing home: 1988-1994. Unpublished manuscript.